Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2025 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

option care health - OPCH

OPCH

Close Chg Chg %
34.95 -0.16 -0.46%

Closed Market

34.79

-0.16 (0.46%)

Volume: 1.26M

Last Updated:

Apr 2, 2025, 4:00 PM EDT

Trade Now

Company Overview: option care health - OPCH

OPCH Key Data

Open

$34.60

 Day Range

34.52 - 35.03

52 Week Range

21.39 - 35.53

 Market Cap

$5.74B

Shares Outstanding

164.24M

 Public Float

162.03M

Beta

1.08

 Rev. Per Employee

N/A

P/E Ratio

28.52

 EPS

$1.24

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

1.82M

  

OPCH Performance

1 Week
 
 0.17%
 
1 Month
 
 3.85%
 
3 Months
 
 47.60%
 
1 Year
 
 8.65%
 
5 Years
 
 334.88%
 

OPCH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About option care health - OPCH

Option Care Health, Inc. engages in the provision of home and alternate site infusion services. The firm provides infusion therapy and other ancillary healthcare services through a national network of full-service pharmacies. The company contracts with managed care organizations, third-party payers, hospitals, physicians, and other referral sources to provide pharmaceuticals and complex compounded solutions to patients for intravenous delivery in the patients’ homes or other nonhospital settings. Its home infusion services consist of anti-infectives, nutrition support, bleeding disorder therapies, immunoglobulin therapy, and other therapies for chronic and acute conditions. The company was founded in 1996 and is headquartered in Bannockburn, IL.

OPCH At a Glance

Option Care Health, Inc.
3000 Lakeside Drive
Bannockburn, Illinois 60015
Phone 1-312-940-2443 Revenue 5.00B
Industry Medical/Nursing Services Net Income 211.82M
Sector Health Services 2024 Sales Growth 16.174%
Fiscal Year-end 12 / 2025 Employees 6,015
View SEC Filings

OPCH Valuation

P/E Current 28.519
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 18.931
Price to Sales Ratio 0.802
Price to Book Ratio 2.747
Price to Cash Flow Ratio 12.40
Enterprise Value to EBITDA 12.497
Enterprise Value to Sales 0.963
Total Debt to Enterprise Value 0.253

OPCH Efficiency

Revenue/Employee 830,956.276
Income Per Employee 35,215.794
Receivables Turnover 10.737
Total Asset Turnover 1.458

OPCH Liquidity

Current Ratio 1.695
Quick Ratio 1.198
Cash Ratio 0.529

OPCH Profitability

Gross Margin 19.049
Operating Margin 6.439
Pretax Margin 5.674
Net Margin 4.238
Return on Assets 6.181
Return on Equity 14.991
Return on Total Capital 8.078
Return on Invested Capital 8.214

OPCH Capital Structure

Total Debt to Total Equity 86.736
Total Debt to Total Capital 46.448
Total Debt to Total Assets 34.544
Long-Term Debt to Equity 84.702
Long-Term Debt to Total Capital 45.359
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Option Care Health - OPCH

Collapse All in section
All values USD millions. 2021 2022 2023 2024 5-year trend
Sales/Revenue
3.44B 3.94B 4.30B 5.00B
Sales Growth
+13.39% +14.72% +9.06% +16.17%
Cost of Goods Sold (COGS) incl D&A
2.72B 3.14B 3.38B 4.05B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
83.97M 85.15M 62.20M 63.50M
Depreciation
50.78M 51.96M 27.82M 29.09M
Amortization of Intangibles
33.19M 33.19M 34.38M 34.41M
COGS Growth
+12.41% +15.29% +7.71% +19.70%
Gross Income
716.55M 806.35M 922.02M 952.08M
Gross Income Growth
+17.28% +12.53% +14.34% +3.26%
Gross Profit Margin
+20.84% +20.44% +21.43% +19.05%
2021 2022 2023 2024 5-year trend
SG&A Expense
525.71M 566.12M 607.43M 630.25M
Research & Development
- - - -
-
Other SG&A
525.71M 566.12M 607.43M 630.25M
SGA Growth
+5.10% +7.69% +7.30% +3.76%
Other Operating Expense
- - - -
-
Unusual Expense
24.93M (1.09M) (52.97M) (11.15M)
EBIT after Unusual Expense
165.92M 241.32M 367.57M 332.98M
Non Operating Income/Expense
6.04M 19.34M 53.40M 11.17M
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
6.03M 5.13M 5.53M 5.96M
Interest Expense
55.46M 54.90M 62.22M 60.56M
Interest Expense Growth
-39.18% -1.02% +13.35% -2.68%
Gross Interest Expense
55.46M 54.90M 62.22M 60.56M
Interest Capitalized
- - - -
-
Pretax Income
116.49M 205.77M 358.74M 283.60M
Pretax Income Growth
+2,321.90% +76.63% +74.34% -20.95%
Pretax Margin
+3.39% +5.22% +8.34% +5.67%
Income Tax
(23.40M) 55.21M 91.65M 71.78M
Income Tax - Current - Domestic
6.82M 13.29M 76.73M 57.84M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(30.22M) 41.93M 14.93M 13.94M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
6.03M 5.13M 5.53M 5.96M
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
139.90M 150.56M 267.09M 211.82M
Minority Interest Expense
- - - -
-
Net Income
139.90M 150.56M 267.09M 211.82M
Net Income Growth
+1,832.27% +7.62% +77.40% -20.69%
Net Margin Growth
+4.07% +3.82% +6.21% +4.24%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
139.90M 150.56M 267.09M 211.82M
Preferred Dividends
- - - -
-
Net Income Available to Common
139.90M 150.56M 267.09M 211.82M
EPS (Basic)
0.7778 0.8313 1.4924 1.2346
EPS (Basic) Growth
+1,843.95% +6.88% +79.53% -17.27%
Basic Shares Outstanding
179.85M 181.10M 178.97M 171.57M
EPS (Diluted)
0.772 0.8269 1.4808 1.2255
EPS (Diluted) Growth
+1,830.94% +7.11% +79.08% -17.24%
Diluted Shares Outstanding
181.21M 182.07M 180.38M 172.84M
EBITDA
274.81M 325.38M 376.80M 385.33M
EBITDA Growth
+32.46% +18.40% +15.80% +2.27%
EBITDA Margin
+7.99% +8.25% +8.76% +7.71%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 37.889
Number of Ratings 11 Current Quarters Estimate 0.386
FY Report Date 06 / 2025 Current Year's Estimate 1.609
Last Quarter’s Earnings 0.35 Median PE on CY Estimate N/A
Year Ago Earnings 1.58 Next Fiscal Year Estimate 1.853
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 9 10 10
Mean Estimate 0.39 0.42 1.61 1.85
High Estimates 0.45 0.45 1.84 2.02
Low Estimate 0.32 0.36 1.30 1.59
Coefficient of Variance 10.11 7.66 9.16 6.71

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 8 8 9
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 1 1 0
SELL 0 0 0
MEAN Overweight Overweight Buy

Insider Actions for Option Care Health - OPCH

Date Name Shares Transaction Value
Feb 27, 2025 John C. Rademacher Chief Executive Officer; Director 752,181 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Luke Whitworth Chief Operating Officer 172,323 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Nicole Maggio Chief Accounting Officer 19,309 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Michael Bavaro Chief Human Resources Officer 61,231 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Femi Adewunmi Chief Medical Officer 20,154 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Christopher Grashoff Chief Growth Officer 36,139 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Collin G. Smyser GC & Corporate Secretary 78,519 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 27, 2025 Michael H. Shapiro Chief Financial Officer 311,933 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2025 Michael H. Shapiro Chief Financial Officer 3,652 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 20, 2025 Luke Whitworth Chief Operating Officer 147,296 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2025 Michael H. Shapiro Chief Financial Officer 290,115 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2025 Michael H. Shapiro Chief Financial Officer 232,721 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $31.46 per share 7,321,402.66
Feb 20, 2025 Michael H. Shapiro Chief Financial Officer 258,738 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $31.46 per share 8,139,897.48
Feb 20, 2025 Michael Bavaro Chief Human Resources Officer 35,253 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $31.46 per share 1,109,059.38
Feb 20, 2025 Michael Bavaro Chief Human Resources Officer 52,472 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Feb 20, 2025 Luke Whitworth Chief Operating Officer 106,403 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $31.46 per share 3,347,438.38
Aug 23, 2024 Elizabeth Quadros Betten Director 21,339 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.09 per share 663,429.51
Aug 23, 2024 Timothy P. Sullivan Director 20,814 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $30.91 per share 643,360.74
Aug 20, 2024 Michael Bavaro Chief Human Resources Officer 43,428 Open market or private sale of non-derivative or derivative security Non-derivative transaction at $31.42 per share 1,364,507.76
Aug 20, 2024 Michael Bavaro Chief Human Resources Officer 1,226 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Option Care Health in the News